Issue Price
₹85
Per Share
GMP
NIL
Grey Market
Est. Listing
₹85
Expected Price
Min. Application
₹272,000
2 lots × 1600 shares
Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases.Beta Drugs Limited is a part of Adley Group, which was founded in the year 1985. Company's manufacturing unit is located at Solan, Himachal Pradesh.Company Strengths:1. Focus on oncology segment. Manufacture over 50 products in this segment.2. 18 product registrations in various countries. Company is in-process of making additional 12 applications for product registration in various countries.
Beta Drugs Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 129,600 | — | ₹1.10 Cr | — |
| TOTAL | 2,296,000 | 100.00% | ₹19.52 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹136,000 |
| Retail (Max) | 13 | 20,800 | ₹1,768,000 |
| sNII (Min) | 14 | 22,400 | ₹1,904,000 |
| bNII (Min) | 68 | 108,800 | ₹9,248,000 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |